LV10490B - Dna sequences coding for proteins having biological activity of husi-i type inhibitors, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins - Google Patents
Dna sequences coding for proteins having biological activity of husi-i type inhibitors, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins Download PDFInfo
- Publication number
- LV10490B LV10490B LVP-93-376A LV930376A LV10490B LV 10490 B LV10490 B LV 10490B LV 930376 A LV930376 A LV 930376A LV 10490 B LV10490 B LV 10490B
- Authority
- LV
- Latvia
- Prior art keywords
- protein
- cusi
- plasmid
- pro
- husi
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19863600571 DE3600571A1 (de) | 1986-01-10 | 1986-01-10 | Dna-sequenzen, die fuer proteine mit der biologischen aktivitaet der husi-typi-inhibitoren codieren, gentechnologische verfahren zur herstellung dieser proteine und diese proteine enthaltende arzneimittel |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| LV10490A LV10490A (lv) | 1995-02-20 |
| LV10490B true LV10490B (en) | 1995-10-20 |
Family
ID=6291649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LVP-93-376A LV10490B (en) | 1986-01-10 | 1993-05-18 | Dna sequences coding for proteins having biological activity of husi-i type inhibitors, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4845076A (ja) |
| EP (1) | EP0232523B1 (ja) |
| JP (2) | JP2533869B2 (ja) |
| AT (1) | ATE88500T1 (ja) |
| AU (1) | AU604003B2 (ja) |
| CA (1) | CA1326216C (ja) |
| DE (2) | DE3600571A1 (ja) |
| DK (1) | DK11187A (ja) |
| ES (1) | ES2054612T3 (ja) |
| HU (1) | HU204888B (ja) |
| IE (1) | IE61526B1 (ja) |
| IL (1) | IL81221A0 (ja) |
| LT (1) | LTIP1753A (ja) |
| LV (1) | LV10490B (ja) |
| PT (1) | PT84089B (ja) |
| ZA (1) | ZA87141B (ja) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6291662B1 (en) | 1984-12-05 | 2001-09-18 | Amgen Inc. | Recombinant methods for production of serine protease inhibitors and DNA sequences |
| US5871956A (en) * | 1984-12-06 | 1999-02-16 | Amgen Inc. | Recombinant methods for production of serine inhibitors and DNA sequences useful for same |
| US6132990A (en) * | 1984-12-06 | 2000-10-17 | Amgen Boulder Inc. | Recombinant methods for production of serine protease inhibitors and DNA sequences useful for same |
| US5900400A (en) * | 1984-12-06 | 1999-05-04 | Amgen Inc. | Serine protease inhibitor analogs |
| US5851983A (en) * | 1987-12-28 | 1998-12-22 | Teijin Limited | Elastase inhibitory polypeptide and process for production thereof by recombinant gene technology |
| CA1340877C (en) * | 1987-12-28 | 2000-01-18 | Takashi Sugiyama | Elastase inhibitory polypeptide and process for production thereof by recombinant gene technology |
| DE3841873A1 (de) * | 1988-12-13 | 1990-06-21 | Gruenenthal Gmbh | Neue serinprotease-inhibitor-proteine, diese enthaltende arzneimittel, dna-sequenzen, die fuer diese proteine codieren und verfahren zur herstellung dieser proteine, arzneimittel und dna-sequenzen |
| IT1235349B (it) * | 1988-12-23 | 1992-06-30 | Biodata Spa | Saggio immunologico per determinazioni in fase omogenea |
| US6869925B1 (en) * | 1992-09-09 | 2005-03-22 | Amgen Inc. | Inhibition of retrovirus infection |
| US6017880A (en) * | 1994-03-09 | 2000-01-25 | Amgen Inc. | Inhibition of retrovirus infection |
| WO1995025539A1 (fr) * | 1994-03-23 | 1995-09-28 | Tokyo Tanabe Company Limited | Nouveau remede contre les maladies virales des voies respiratoires |
| US5633227A (en) * | 1994-09-12 | 1997-05-27 | Miles, Inc. | Secretory leukocyte protease inhibitor as an inhibitor of tryptase |
| US6544740B1 (en) | 1999-07-01 | 2003-04-08 | Reprogen, Inc. | Treatment of endometriosis with antileukoprotease |
| EP1400247A1 (en) * | 1999-07-01 | 2004-03-24 | Reprogen, Inc. | Treatment of endometriosis with antileukoprotease |
| US7247704B2 (en) * | 2000-12-18 | 2007-07-24 | Arriva Pharmaceuticals, Inc. | Multifunctional protease inhibitors and their use in treatment of disease |
| WO2003018620A2 (en) * | 2001-08-27 | 2003-03-06 | Les Laboratoires Aeterna Inc. | Serine protease inhibitor and processes for the preparation thereof |
| GB2532488B (en) * | 2014-11-21 | 2019-07-31 | Univ Of The Western Cape | Use of AMP1 or AMP8 to diagnose HIV infection |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL95223A (en) * | 1984-12-06 | 1992-08-18 | Synergen Biolog Inc | Dna sequence for production of serine protease inhibitors |
| DE3587526T3 (de) * | 1984-12-06 | 2002-08-08 | Amgen Inc.(N.D.Ges D. Staates Delaware), Thousand Oaks | Serinproteaseinhibitoren und isolierungsverfahren dazu. |
| JPS62501291A (ja) * | 1984-12-06 | 1987-05-21 | サイナ−ゲン バイオロジカルズ，インコ−ポレ−テツド | 精製セリンプロテアーゼインヒビターおよびこれを含有する医薬組成物 |
-
1986
- 1986-01-10 DE DE19863600571 patent/DE3600571A1/de not_active Withdrawn
- 1986-12-16 ES ES86117504T patent/ES2054612T3/es not_active Expired - Lifetime
- 1986-12-16 DE DE8686117504T patent/DE3688324D1/de not_active Expired - Fee Related
- 1986-12-16 EP EP86117504A patent/EP0232523B1/de not_active Expired - Lifetime
- 1986-12-16 AT AT86117504T patent/ATE88500T1/de not_active IP Right Cessation
-
1987
- 1987-01-08 ZA ZA87141A patent/ZA87141B/xx unknown
- 1987-01-09 CA CA000527073A patent/CA1326216C/en not_active Expired - Fee Related
- 1987-01-09 US US07/001,938 patent/US4845076A/en not_active Expired - Fee Related
- 1987-01-09 HU HU8779A patent/HU204888B/hu not_active IP Right Cessation
- 1987-01-09 PT PT84089A patent/PT84089B/pt not_active IP Right Cessation
- 1987-01-09 AU AU67452/87A patent/AU604003B2/en not_active Ceased
- 1987-01-09 JP JP62003084A patent/JP2533869B2/ja not_active Expired - Lifetime
- 1987-01-09 DK DK011187A patent/DK11187A/da not_active Application Discontinuation
- 1987-01-09 IL IL81221A patent/IL81221A0/xx not_active IP Right Cessation
- 1987-01-09 IE IE5587A patent/IE61526B1/en not_active IP Right Cessation
-
1993
- 1993-05-18 LV LVP-93-376A patent/LV10490B/en unknown
- 1993-12-31 LT LTIP1753A patent/LTIP1753A/xx unknown
-
1995
- 1995-04-10 JP JP7083931A patent/JP2659525B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2054612T3 (es) | 1994-08-16 |
| PT84089A (en) | 1987-02-01 |
| CA1326216C (en) | 1994-01-18 |
| JP2659525B2 (ja) | 1997-09-30 |
| IE61526B1 (en) | 1994-11-16 |
| EP0232523A2 (de) | 1987-08-19 |
| JPH07300500A (ja) | 1995-11-14 |
| US4845076A (en) | 1989-07-04 |
| IE870055L (en) | 1987-07-10 |
| ZA87141B (en) | 1987-08-26 |
| HUT43106A (en) | 1987-09-28 |
| PT84089B (pt) | 1989-02-28 |
| DK11187A (da) | 1987-07-11 |
| AU6745287A (en) | 1987-07-16 |
| EP0232523A3 (en) | 1988-12-07 |
| LTIP1753A (en) | 1995-07-25 |
| IL81221A0 (en) | 1987-08-31 |
| JPS62259591A (ja) | 1987-11-11 |
| AU604003B2 (en) | 1990-12-06 |
| JP2533869B2 (ja) | 1996-09-11 |
| DE3600571A1 (de) | 1987-08-06 |
| EP0232523B1 (de) | 1993-04-21 |
| LV10490A (lv) | 1995-02-20 |
| HU204888B (en) | 1992-02-28 |
| DK11187D0 (da) | 1987-01-09 |
| DE3688324D1 (de) | 1993-05-27 |
| ATE88500T1 (de) | 1993-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4845076A (en) | DNA sequences coding for proteins having the biological activity of HUSI-type I inhibitors, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins | |
| US5824505A (en) | Vectors, transformed cells and process for the preparation of hirudin | |
| Heinzel et al. | Molecular cloning and expression of cDNA for human antileukoprotease from cervix uterus | |
| EP0621871B1 (en) | A human kunitz-type protease inhibitor variant | |
| US5464822A (en) | Polypeptides and polypeptide analogues | |
| JPH07506334A (ja) | ヒトＫｕｎｉｔｚ型プロテアーゼ阻害剤変異体 | |
| JPH07504891A (ja) | ヒトクニッツ型プロテアーゼインヒビターの変異体 | |
| HUT70291A (en) | A novel human kunitz-type protease inhibitor and variants thereof | |
| AU625018B2 (en) | Variants of pai-2 | |
| AU632361B2 (en) | Recombinant aprotinin variants - genetically engineered process for the microbial preparation of homogeneously processed aprotinin variants and the therapeutic use thereof | |
| CA1341165C (en) | Active site modified protease alpha-1-antitrypsin inhibitors and their production | |
| US5705355A (en) | Hirudin, pharmaceutical compositions comprising it and their use | |
| AU2004225718B2 (en) | Inhibitor proteins of a protease and use thereof | |
| KR980009283A (ko) | 특성이 개선된 아프로티닌 변이체 | |
| AU705267B2 (en) | Process for preparing recombinant aprotinin and recombinant aprotinin variants having the natural N-terminal sequence | |
| US5231010A (en) | Recombinant aprotinin variants genetically engineered process for the microbial preparation of homogeneously processed aprotinin variants and the therapeutic use thereof | |
| JPS61501609A (ja) | ヒルジンの発現のためのベクタ−、形質転換細胞及びヒルジンの製造方法 | |
| Cook et al. | Expression and Purification of Recombinant Tick Anticoagulant Peptide (Y1W/D10R) Double Mutant Secreted bySaccharomyces cerevisiae | |
| CA1340971C (en) | Metalloproteinase inhibitor sequence recombinant vector system for using the same and recombinant-dna method for the manufacture of same | |
| JPH09124700A (ja) | 新規プロテアーゼインヒビターおよびその製造方法、エラスターゼが関与する疾患の治療剤 |